Instructions
Please read this page carefully. You will need to scroll down this page and ensure that you have read the learning objectives, accreditation information, and potential conflicts of interest disclosures for the authoring faculty. Please check the box to agree to the terms of understanding and click the "Start Module" button on the bottom of the page to begin your learning activity.

Learning Objectives
After completing this learning activity, participants should be better able to:

• Interpret and synthesize treatment guidelines for major depression, as published by 4 major national mental health organizations
• Evaluate appropriate psychopharmacologic therapy options in 2 common depressive disorder scenarios
• Describe common potential side effects of major classes of antidepressants
• Follow current recommended treatment guidelines for a patient with depression who has prominent comorbid anxiety
• Clarify current recommended treatment options for a patient with depression who achieves a partial response after monotherapy with antidepressant medication
• Deliver high quality psychiatric care, consistent with clinical guidelines published in the United States, the United Kingdom, and Canada

Accreditation
This learning activity has been designated for 1.75 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in this activity.
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Target Audience
This learning activity is intended for a broad audience of healthcare practitioners, including primary care physicians, family physicians, emergency medicine physicians, psychiatrists, psychologists, nurse practitioners, and physician assistants or other healthcare professionals with an interest in treating patients with Bipolar Disorder.

Disclosure Statements
To view the Disclosure Statements, please click here.